# Nefopam Versus Ondansteron for Prevention of Post Spinal Shivering.

> **NCT04870541** · PHASE4 · UNKNOWN · sponsor: **Saint-Joseph University** · enrollment: 150 (estimated)

## Conditions studied

- Shivering
- Adverse Effects in the Therapeutic Use of Anaesthetic

## Interventions

- **DRUG:** Ondansetron 8mg
- **DRUG:** Nefopam Injectable Solution

## Key facts

- **NCT ID:** NCT04870541
- **Lead sponsor:** Saint-Joseph University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2021-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04870541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04870541, "Nefopam Versus Ondansteron for Prevention of Post Spinal Shivering.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04870541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*